Company: REVB
Filing Date: 2025-11-12
Form Type: S-8
Source: 0001193125-25-277581
Chunk: 1

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: S-8
Chunk 1
---
 Inc. (the “Registrant”) issuable under the 2021 Equity Incentive Plan (the “Plan”). The Registrant previously filed Registration Statements on Form S-8 covering Common Stock issuable under the Plan (File Nos. 333-265329, 333-273933, and 333-280313) (the “Prior Registration Statements”).

Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statements are incorporated by reference in this Registration Statement to the extent not modified or superseded hereby or by any subsequently filed document which is incorporated by reference herein or therein.

Item 2. Registrant Information and Employee Plan Annual Information

Upon written or oral request, any of the documents incorporated by reference in Item 3 of Part II of this registration statement (which are incorporated by reference in this Section 10(a) Prospectus) and any other documents required to be delivered to eligible employees, nonemployee directors, and consultants pursuant to Rule 428(b) are available, without charge, by contacting:

<div align='center'>Chester S. Zygmont, III, Chief Financial Officer

Revelation Biosciences, Inc.

4660 La Jolla Village Drive, Suite 100

San Diego, California 92122

650-800-3717</div>

PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3. Incorporation of Documents by Reference The following documents, as filed with the SEC by Revelation Biosciences, Inc., a Delaware corporation (File No. 001-39603) (the “Company”), pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or the Securities Act are hereby incorporated by reference:

| (iv) | All other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant Annual Report; and |

| (v) | The description of the Company’s common stock contained in its registration statement on Form S-1 (Registration No. 333-287423) filed with the SEC on May 23, 2025. |

All other documents filed by the Company with the SEC pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act after the date of this registration statement and before the filing of a post-effective amendment to this registration statement that indicate that all securities offered hereby have been sold, or that dereg